Vision RT Launches Patient Website that Educates on Radiation Therapy Treatment Options

30th September 2019
aandersen

Lisa Sweeney lsweeney@visionrt.com

Vision RT is excited to introduce its new website for patients, AlignRTEdu.com.  This site is designed to empower patients and caregivers with the resources, knowledge, and support they need to help make an educated decision about their treatment options.

AlignRTEdu.com features general information about radiation therapy for many types of cancer, including breast, brain, lung, and pediatrics.  It provides valuable information to patients and caregivers about potential radiation treatment side effects, such as cardiac risks for left breast cancer patients.

AlignRTEdu.com also contains information about clinics who use AlignRT® to avoid tattooing / marking patients. This is a growing trend in radiotherapy, responding to published data on the psychological impact of these marks.  Links to patient advocacy resources and wellness, lifestyle, and treatment tips are also available on the site, together with a map of where many of the 1,100+ clinical systems can be found.

Norman Smith, CEO of Vision RT, said “Delivering shared decision-making to patients means educating them on the risks and benefits of different treatments. With the growing trend towards advanced forms of cardiac sparing and tattooless treatments, we’re pleased to be able to help in this education process with AlignRTEdu.com.”

 

About Vision RT

Vision RT defines the standard of care in Surface Guided Radiation Therapy. We provide superior solutions for the radiotherapy market, with products installed in many of the leading treatment centers in the world, including around 70% of the 50 US News “Best Hospitals for Cancer”. With approximately 70 granted patents plus more than 50 pending, we continue to innovate in the radiation oncology space and are committed to making SGRT the standard of care for all patients, worldwide.

Vision RT is part of the William Demant Invest (WDI) family, a leading Danish Medtech investor with a long-term investment perspective. The companies in WDI employ more than 18,000 people, with a total annual revenue of more than $3 billion.